| |
|
Headlines:
|
 |
Back to Oncology Labs
Neuron-specific enolase (NSE)
Neuron-specific enolase (NSE) has been detected in patients with
neuroblastoma; small cell lung cancer; Wilms' tumor; melanoma; and
cancers of the thyroid, kidney, testicle, and pancreas. However,
studies of NSE as a tumor marker have concentrated primarily on
patients with neuroblastoma and small cell lung cancer.
Measurement of NSE level in patients with these two diseases can provide information
about the extent of the disease and the patient's prognosis, as well
as about the patient's response to treatment.
|
|
|
|
Are you a doctor or a nurse?
Do you want to join the Doctors Lounge online medical community?
Participate in editorial activities (publish, peer review, edit) and
give a helping hand to the largest online community of patients.
Click on the link below to see the requirements:
Doctors Lounge Membership
Application |
|
|
|
send
to a friend
printer
friendly version
